Technology, study and use of anti-tuberculosis drugs isoniazid, pyrazinamide, rifampicin and ethambutol
Yu. A. Egoshina , A. A. Samartsev , L. A. Potselueva , R. Sh. Valiev , T. N. Galiullina
Kazan medical journal ›› 2000, Vol. 81 ›› Issue (2) : 144 -145.
Technology, study and use of anti-tuberculosis drugs isoniazid, pyrazinamide, rifampicin and ethambutol
At present, the effectiveness of the treatment of patients with tuberculosis in Russia has significantly decreased in comparison with the literature data for the period from 1992 to 1997. For example, the cure rates of patients with respiratory lesions decreased by 25.1%, abacillation - by 27%, closure of decay cavities - by 20.2% [4].
Eco-Vector
/
| 〈 |
|
〉 |
PDF
